Cerebral Revascularization in the Very Young

Moyamoya disease can progress quickly in children under age three, putting them at risk for stroke. Revascularization presents challenges but is often the best treatment option.

CDM1 Clinical Study Yields Encouraging Results

The first clinical study for congenital myotonic dystrophy type 1 is set to transition to a Phase II/III trial.

Learn more

Using A.I. to ID Epilepsy Surgery Candidates

Researchers at Cincinnati Children’s have developed a novel algorithm to help providers know when it might be time for an epilepsy surgery referral.

Angioma Alliance Recognizes Cerebrovascular Disease Center

The Cerebrovascular Disease Center at Cincinnati Children’s becomes just the second pediatric program to be named a Clinical Center of Excellence for Cavernous Angioma.

Rett Syndrome Clinic Gains Momentum

Dr. Shannon Standridge’s personal desire to care for people with Rett syndrome spread quickly to include multiple specialists across the medical center.

Learn more